Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis
Benedikt Hofer(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Philipp Königshofer(Medical University of Vienna), Ksenia Brusilovskaya(Austrian Academy of Sciences), Benedikt Simbrunner(Austrian Academy of Sciences), Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Philipp Schwabl(Austrian Academy of Sciences), Carolin Lackner(Ludwig Boltzmann Institute Applied Diagnostics), Georg Semmler(University of Southern Denmark), Oleksandr Petrenko(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Thomas Sorz‐Nechay(Austrian Academy of Sciences), Katharina Regnat(Medical University of Vienna), Kerstin Zinober(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna)
Cited by 8
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399